Jasper Therapeutics, Inc. (JSPR) Insider Traders

$7.02

north_east
$0.03 (0.43%)
Day's range
$6.57
Day's range
$7.43

Jasper Therapeutics, Inc. Insider Transactions

Jasper Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
EMSTER KURT VON

Director

Sell 9,075 @ $1.49 $13,524 21,175 04/13/2023 04/14/2023
Lis William

Director

Sell 8,500 @ $1.44 $12,240 61,486 04/13/2023 04/14/2023
EMSTER KURT VON

Director

Sell 9,075 @ $1.49 $13,524 21,175 04/13/2023 04/14/2023
Lis William

Director

Sell 8,500 @ $1.44 $12,240 61,486 04/13/2023 04/14/2023
Buy 2,666,666 @ $1.50 $4.00 M 8,519,648 01/27/2023 04/11/2023
Buy 2,666,666 @ $1.50 $4.00 M 8,519,648 01/27/2023 04/11/2023
Carlyle Group Inc.

10 percent owner

Buy 3,133,333 @ $1.50 $4.70 M 8,761,891 01/27/2023 01/31/2023
Carlyle Group Inc.

10 percent owner

Buy 3,133,333 @ $1.50 $4.70 M 8,761,891 01/27/2023 01/31/2023
Sell 75,000 @ $1.89 $141,750 4,549,606 01/25/2023 01/26/2023
Sell 75,000 @ $1.89 $141,750 4,549,606 01/25/2023 01/26/2023
Page 2 of 2

Jasper Therapeutics, Inc. FAQ's

Who is on Jasper Therapeutics, Inc.'s Insider Roster?

The list of insiders at Jasper Therapeutics, Inc. includes Carlyle Group Inc., Velan Capital Investment Management LP, Mahal Jeetinder Singh.

How much insider selling is happening at Jasper Therapeutics, Inc.?

Insiders have sold a total of 1,800 Jasper Therapeutics, Inc. shares in the last 12 months for a total of 45,532 sold.

Which Jasper Therapeutics, Inc. insiders have been selling company stock?

The following insiders have sold Jasper Therapeutics, Inc. shares in the last 12 months: Mahal Jeetinder Singh ($45,532),

How much insider buying is happening at Jasper Therapeutics, Inc.?

Insiders have purchased a total of 540,000 Jasper Therapeutics, Inc. shares in the last 12 months for a total of 6.99 M.

Which Jasper Therapeutics, Inc. insiders have been buying company stock?

The following insiders have purchased Jasper Therapeutics, Inc. shares in the last 12 months: Carlyle Group Inc. ($2.46 M), Velan Capital Investment Management LP ($4.53 M),